Evan A. Facher
Keine laufenden Positionen mehr
Profil
Dr. Evan A.
Facher is President & Chief Executive Officer at SironRX Therapeutics, Inc.
Dr. Facher was previously employed as GM-Global Cardiovascular Fluid Delivery Business by Bayer Medical Care, Inc. and a Principal by Athersys, Inc.
He received his undergraduate degree from the University of Miami (Florida), an MBA from the Weatherhead School of Management, and a doctorate degree from the University of Pittsburgh.
Ehemalige bekannte Positionen von Evan A. Facher
| Unternehmen | Position | Ende |
|---|---|---|
Bayer Medical Care, Inc.
 Bayer Medical Care, Inc. Medical SpecialtiesHealth Technology Bayer Medical Care, Inc. engages in the manufacture of medical equipment and disposable products. The company was founded on January 25, 1996 and is headquartered in Indianola, PA. | Corporate Officer/Principal | - |
| ATHERSYS, INC. | Corporate Officer/Principal | - |
SironRX Therapeutics, Inc.
 SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | Vorstandsvorsitzender | - |
Ausbildung von Evan A. Facher
| Weatherhead School of Management | Masters Business Admin |
| University of Pittsburgh | Doctorate Degree |
| University of Miami | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | Health Services |
Bayer Medical Care, Inc.
Bayer Medical Care, Inc. Medical SpecialtiesHealth Technology Bayer Medical Care, Inc. engages in the manufacture of medical equipment and disposable products. The company was founded on January 25, 1996 and is headquartered in Indianola, PA. | Health Technology |